Evidence map›Paper›PMID 31340975›Full record

ArticleBMJ open2019

Surveillance arterioveNous fistulAs using ultRasound (SONAR) trial in haemodialysis patients: a study protocol for a multicentre observational study.

James Richards, Mohammed Hossain, Dominic Summers, Matthew Slater, Matthew Bartlett, Vasilis Kosmoliaptsis, Edward Cf Wilson, Regin Lagaac, Anna Sidders, Claire Foley and 23 more

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 18 institutions in 7 countries.

James RichardsDepartment of Surgery, Addenbrooke's Hospital, Cambridge, UK.ORCID 0000-0001-9049-5745
Mohammed HossainDepartment of Surgery, Addenbrooke's Hospital, Cambridge, UK.
Dominic SummersDepartment of Surgery, Addenbrooke's Hospital, Cambridge, UK.
Matthew SlaterVascular Studies Unit, Addenbrooke's Hospital, Cambridge, UK.
Matthew BartlettDepartment of Nephrology and Renal Transplantation, Royal Free London NHS Foundation Trust, London, UK.
Vasilis KosmoliaptsisDepartment of Surgery, Addenbrooke's Hospital, Cambridge, UK.ORCID 0000-0001-7298-1387
Edward Cf WilsonCambridge Centre for Health Services Research, University of Cambridge, Cambridge, UK.ORCID 0000-0002-8369-1577
Regin LagaacCambridge Dialysis Centre, Cambridge University Hospitals, Cambridge.
Anna SiddersClinical trials Unit, NHS Blood and Transplant, Cambridge, UK.
Claire FoleyClinical trials Unit, NHS Blood and Transplant, Cambridge, UK.
Emma LaingClinical trials Unit, NHS Blood and Transplant, Cambridge, UK.ORCID 0000-0002-8309-0990
Valerie HopkinsClinical trials Unit, NHS Blood and Transplant, Cambridge, UK.
Chloe Fitzpatrick-CreamerClinical trials Unit, NHS Blood and Transplant, Cambridge, UK.
Cara HudsonClinical trials Unit, NHS Blood and Transplant, Cambridge, UK.
Helen ThomasClinical trials Unit, NHS Blood and Transplant, Cambridge, UK.
Sam TurnerRenal and Transplant, North Bristol NHS Trust, Westbury on Trym, UK.
Andrew TambyrajaDepartment of Clinical Surgery, Royal Infirmary of Edinburgh, Edinburgh, UK.
Subash SomalankaDepartment of Nephrology, Epsom and St Helier University Hospitals NHS Trust, Epsom, UK.
James HunterRenal transplantation and nephrology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
Sam DuttaNottingham Renal and Kidney Transplant Unit, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Sarah LawmanSussex Kidney Unit, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
Tracey SalterDepartment of Nephrology, Epsom and St Helier University Hospitals NHS Trust, Epsom, UK.ORCID 0000-0002-4857-0358
Mohammed AslamDepartment of Vascular Surgery, Imperial College London Department of Surgery and Cancer, London, UK.
Atul BagulDepartment of Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK.
Rajesh SivaprakasamDepartment of Surgery, Barts Health NHS Trust, London, UK.
George SmithHull York Medical School, Hull University Teaching Hospitals NHS Trust, Hull, UK.
Zia MoinuddinRenal Transplant Unit, Manchester University NHS Foundation Trust, Manchester, UK.
Simon KnightNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Paul GibbsRenal Transplant Department, Portsmouth Hospitals NHS Trust, Portsmouth Hospitals NHS Trust, Portsmouth, UK.
Reza MotallebzadehDepartment of Nephrology and Renal Transplantation, Royal Free London NHS Foundation Trust, London, UK.
Nicholas BarnettTransplant Unit, Guy's and Saint Thomas' Hospitals NHS Trust, London, UK.
Gavin PettigrewDepartment of Surgery, Addenbrooke's Hospital, Cambridge, UK.
SONAR trial group
NHS Blood and Transplant · GBUniversity of Cambridge · GBAddenbrooke's Hospital · GBEpsom and St Helier University Hospitals NHS Trust · GBRoyal Free London NHS Foundation Trust · GBBarts Health NHS Trust · GBEdinburgh Royal Infirmary · GBImperial College London · GBManchester University NHS Foundation Trust · GBNorth Bristol NHS Trust · GBNottingham University Hospitals NHS Trust · GBPortsmouth Hospitals NHS Trust · GBSaint Thomas West Hospital · USUniversity Hospitals Coventry and Warwickshire NHS Trust · GBUniversity Hospitals of Leicester NHS Trust · GBUniversity Hospitals Sussex NHS Foundation Trust · GBUniversity of Oxford · GBUniversity Teaching Hospital · ZM

Funding

Department of Health HTA/17/27/11Department of Health PDF-2016-09-065
6 · The paper itself

Abstract

introductionArteriovenous fistulas (AVFs) are considered the best and safest modality for providing haemodialysis in patients with end-stage renal disease. Only 20% of UK centres achieve the recommended 80% target for achieving dialysis of the prevalent dialysis population via permanent access (as opposed to a central venous catheter). This is partly due to the relatively poor maturation rate of newly created fistulas, with as many as 50% of fistulas failing to mature.The Surveillance Of arterioveNous fistulAe using ultRasound study will examine whether a protocolised programme of Doppler ultrasound (US) surveillance can identify, early after creation, potentially correctable problems in those AVFs that subsequently fail to mature. METHODS AND ANALYSIS: This is a multicentre observational study that will assess newly created AVFs by Doppler US performed at 2, 4, 6 and 10 weeks after creation. The primary outcome measure will be primary fistula patency at week 10. Secondary outcome measures include: successful use of the fistula; clinical suitability for dialysis; creation of new fistula or radiological salvage; fistula thrombosis; secondary fistula patency rate and patient acceptability. ETHICS AND DISSEMINATION: The study has been approved by the Cambridgeshire and Hertfordshire Research Ethics Committee and by the Health Research Authority (REC 18/EE/0234). The results generated from this work will be published as open access, within 3 years of trial commencement. We will also present our findings at key national/international renal meetings, as well as support volunteers at renal patient groups to disseminate the trial outcome. TRIAL REGISTRATION NUMBER: ISRCTN36033877.

Indexed as

Arteriovenous Shunt, SurgicalRenal DialysisArteriovenous FistulaHumansMulticenter Studies as TopicObservational Studies as TopicUltrasonography, DopplerVascular Patencydialysisend stage renal failuresurgeryultrasound

Identifiers

PMID31340975
PMCPMC6661628
OpenAlexW2963567323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.